HRSA-22-110: Promoting Resilience and Mental Health Among Health Professional Workforce (PRMHW)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 10 awards worth $29.6 million in total. Applications closed on September 22, 2021.
From the official notice on Grants.gov, last changed September 20, 2021. Checked November 7, 2026.
- Total funding$29.6 million
- Expected awards10
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | July 16, 2021 |
|---|---|
| Deadline | September 22, 2021 |
| Archived by Grants.gov | November 19, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants are entities that provide health care, including health care providers associations, and FQHCs.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The purpose of this program is to provide support to entities providing health care, health care providers associations, and Federally Qualified Health Centers (FQHCs), taking into consideration the needs of rural and medically underserved communities, to establish, enhance, or expand evidence informed or evidenced-based programs or protocols to promote resilience, mental health, and wellness among their providers, other personnel, and members, collectively known as the “Health Workforce.”
Who has won Mental and Behavioral Health Education and Training Grants grants before
From fiscal 2021 to 2025, Mental and Behavioral Health Education and Training Grants (93.732) awarded $770 million across 544 grant awards, an average of $1.4 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of Wisconsin System | Wisconsin | 2 | $12.5 million |
| University of Utah | Utah | 5 | $9.4 million |
| University of Arizona | Arizona | 5 | $9.4 million |
| Loma Linda University | California | 5 | $7.2 million |
| The General Hospital Corporation | Massachusetts | 3 | $6.6 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-110 still open?
No. It closed on September 22, 2021.
Who can apply for Promoting Resilience and Mental Health Among Health Professional Workforce (PRMHW)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Promoting Resilience and Mental Health Among Health Professional Workforce (PRMHW)?
Closed September 22, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $29.6 million in total across about 10 awards.
Who has won Mental and Behavioral Health Education and Training Grants grants before?
The largest recipients over five fiscal years were University of Wisconsin System, University of Utah, University of Arizona. The program made 544 awards worth $770 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)